Rating Lowered on Powerhouse Finance's Class A FCC Units; B and C Units Affirmed May 02

  • ID: 2031570
  • May 2002
  • Standard & Poors
1 of 3

LONDON (Standard & Poor's) May 28, 2002--Standard & Poor's said today that it lowered its rating on the class A units issued by Powerhouse Finance, a Fonds Commun de Créances (FCC) set up under French law. At the same time, the ratings on the class B and C units were affirmed (see list below). The collateral in the portfolio is a receivable from a bank loan extended by Deutsche Bank AG to Société d'Edification de Logements Economiques (SELEC). The loan will be repaid from the rental income generated by Electricité de France's (EDF; AA/Negative/A-1+) lease on the portfolio of 10,168 residential properties located in France, and from disposal proceeds. "The rating action follows the recent downgrade of EDF to 'AA'...

Companies mentioned in this report are:
- Deutsche Bank AG
- Electricite de France S.A.

Action: Various Rating Actions

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Deutsche Bank AG
- Electricite de France S.A.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.